Title:
TPO MIMETIC FUSION PROTEINS AND METHODS OF USE SUBMISSION OF SEQUENCE LISTING AS ASCII TEXT FILE
Document Type and Number:
WIPO Patent Application WO/2023/044774
Kind Code:
A1
Abstract:
Provided are recombinant peptides comprising a recombinant human p75 TNF receptor and TPO mimetic peptides linked by an Fc fragment of IgG1. The recombinant peptides can form a homodimer by inter-chain disulfide bond in the Fc region and can have six TPOR binding and/or activating domain in the C-terminus. The recombinant peptides provided herein are useful for increasing platelet count, e.g., for treating thrombocytopenia. Also provided herein are methods for producing the recombinant peptides, formulations and therapeutic methods.
More Like This:
Inventors:
LIANG PENG (CN)
Application Number:
PCT/CN2021/120388
Publication Date:
March 30, 2023
Filing Date:
September 24, 2021
Export Citation:
Assignee:
SICHUAN CLOVER BIOPHARMACEUTICALS INC (CN)
International Classes:
C07K19/00; A61K38/16; A61P7/04; C12N15/62; C12N15/64; C12N15/86
Domestic Patent References:
WO2003024384A2 | 2003-03-27 |
Foreign References:
CN101103045A | 2008-01-09 | |||
CN112494658A | 2021-03-16 | |||
CN102382850A | 2012-03-21 | |||
CN1325447A | 2001-12-05 |
Attorney, Agent or Firm:
MERITS & TREE (CN)
Download PDF: